# Monopar Therapeutics: filings

MNPR · Nasdaq · CIK 1645469 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mnpr.md) · [Financials](/companies/mnpr/financials.md) · [Filings](/companies/mnpr/filings.md) · [Insiders](/companies/mnpr/insiders.md)

## Reports and events: 178 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 222, 8-K 118, 10-Q 26, 3 19, CORRESP 14, 144 11, SCHEDULE 13G/A 11, UPLOAD 11, 10-K 9, 424B5 7, DEF 14A 7, DEFA14A 6, EFFECT 6, S-1/A 6, S-3 5, S-8 5, ARS 4, D 4, S-8 POS 4, SC 13G 4, 10-Q/A 3, 4/A 3, SCHEDULE 13D/A 3, 10-12G/A 2, 10-K/A 2, 424B3 2, DEF 14C 2, SC 13D 2, SCHEDULE 13G 2, 10-12G 1, 144/A 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, CT ORDER 1, FWP 1, PRE 14A 1, S-1 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 13:30 ET | [8-K](/filings/0001437749-26-027165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027165 |
| 2026-08-12 | 13:30 ET | [10-Q](/filings/0001437749-26-027164.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027164 |
| 2026-07-22 | 12:00 ET | [8-K](/filings/0001437749-26-024041.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-024041 |
| 2026-06-30 | 12:00 ET | [8-K](/filings/0001437749-26-022086.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-022086 |
| 2026-06-26 | 20:06 ET | [8-K](/filings/0001437749-26-021832.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-021832 |
| 2026-06-23 | 12:00 ET | [8-K](/filings/0001437749-26-021350.md) | 5.07 Shareholder vote results | 0001437749-26-021350 |
| 2026-05-29 | 20:56 ET | [8-K](/filings/0001437749-26-018896.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-018896 |
| 2026-05-19 | 21:26 ET | [8-K](/filings/0001437749-26-017821.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-017821 |
| 2026-05-14 | 18:00 ET | [10-Q](/filings/0001437749-26-016982.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016982 |
| 2026-05-14 | 18:00 ET | [8-K](/filings/0001437749-26-016981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016981 |
| 2026-04-30 | 20:01 ET | [DEF 14A](/filings/0001437749-26-014183.md) | Proxy statement, period 2026-06-22 | 0001437749-26-014183 |
| 2026-04-20 | 10:22 ET | [8-K](/filings/0001437749-26-012751.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-012751 |
| 2026-04-01 | 16:24 ET | [10-K/A](/filings/0001437749-26-010841.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-010841 |
| 2026-03-27 | 17:27 ET | [8-K](/filings/0001437749-26-010030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-010030 |
| 2026-03-27 | 17:00 ET | [10-K](/filings/0001437749-26-010025.md) | Annual report, period 2025-12-31 | 0001437749-26-010025 |
| 2026-03-02 | 13:01 ET | [8-K](/filings/0001437749-26-006229.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-006229 |
| 2026-01-30 | 19:32 ET | [SCHEDULE 13D/A](/filings/0001437749-26-002528.md) | Ownership report, active investor, amended | 0001437749-26-002528 |
| 2025-11-13 | 13:00 ET | [8-K](/filings/0001437749-25-034618.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034618 |
| 2025-11-13 | 13:00 ET | [10-Q](/filings/0001437749-25-034617.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034617 |
| 2025-11-10 | 13:00 ET | [8-K](/filings/0001437749-25-033948.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-033948 |
| 2025-09-24 | 00:59 ET | [SCHEDULE 13D/A](/filings/0001437749-25-029839.md) | Ownership report, active investor, amended | 0001437749-25-029839 |
| 2025-09-24 | 21:06 ET | [8-K](/filings/0001437749-25-029819.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029819 |
| 2025-09-15 | 11:00 ET | [8-K](/filings/0001437749-25-029005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-029005 |
| 2025-08-12 | 12:01 ET | [8-K](/filings/0001437749-25-026043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-026043 |
| 2025-08-12 | 12:00 ET | [10-Q](/filings/0001437749-25-026042.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026042 |
| 2025-06-23 | 22:00 ET | [8-K](/filings/0001437749-25-020959.md) | 5.07 Shareholder vote results | 0001437749-25-020959 |
| 2025-05-13 | 12:00 ET | [10-Q](/filings/0001437749-25-016263.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016263 |
| 2025-05-13 | 12:00 ET | [8-K](/filings/0001437749-25-016262.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-016262 |
| 2025-05-07 | 10:00 ET | [8-K](/filings/0001437749-25-014880.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-014880 |
| 2025-04-30 | 19:34 ET | [DEF 14A](/filings/0001437749-25-013824.md) | Proxy statement, period 2025-06-17 | 0001437749-25-013824 |
| 2025-03-31 | 12:04 ET | [8-K](/filings/0001437749-25-009982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-009982 |
| 2025-03-31 | 12:00 ET | [10-K](/filings/0001437749-25-009979.md) | Annual report, period 2024-12-31 | 0001437749-25-009979 |
| 2025-03-03 | 22:15 ET | [8-K](/filings/0001437749-25-005951.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-005951 |
| 2025-02-24 | 22:15 ET | [8-K](/filings/0001437749-25-004910.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-004910 |
| 2025-02-07 | 22:01 ET | [SCHEDULE 13D/A](/filings/0001437749-25-003178.md) | Ownership report, active investor, amended | 0001437749-25-003178 |
| 2024-12-23 | 21:06 ET | [8-K](/filings/0001437749-24-038286.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001437749-24-038286 |
| 2024-12-17 | 22:01 ET | [SC 13D/A](/filings/0001437749-24-037745.md) | Ownership report, active investor, amended | 0001437749-24-037745 |
| 2024-12-06 | 13:00 ET | [8-K](/filings/0001437749-24-036825.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-036825 |
| 2024-11-08 | 13:02 ET | [8-K](/filings/0001437749-24-034049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034049 |
| 2024-11-08 | 13:01 ET | [10-Q](/filings/0001437749-24-034048.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034048 |
| 2024-10-30 | 20:05 ET | [8-K](/filings/0001437749-24-032612.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-032612 |
| 2024-10-24 | 11:00 ET | [8-K](/filings/0001437749-24-031957.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-031957 |
| 2024-10-22 | 12:00 ET | [8-K](/filings/0001437749-24-031684.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031684 |
| 2024-10-15 | 12:00 ET | [8-K](/filings/0001437749-24-031184.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031184 |
| 2024-10-07 | 12:00 ET | [8-K](/filings/0001437749-24-030764.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-030764 |
| 2024-09-12 | 12:00 ET | [8-K](/filings/0001437749-24-029012.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-029012 |
| 2024-08-27 | 20:07 ET | [8-K](/filings/0001437749-24-027846.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027846 |
| 2024-08-21 | 12:00 ET | [8-K](/filings/0001437749-24-027432.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-027432 |
| 2024-08-14 | 12:00 ET | [8-K](/filings/0001437749-24-026563.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026563 |
| 2024-08-09 | 12:02 ET | [10-Q](/filings/0001437749-24-025651.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025651 |

Page 1 of 4. [Older](/companies/mnpr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.